A phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple negative breast cancer
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Atezolizumab (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions
- 15 Dec 2015 New trial record
- 11 Dec 2015 Early data presented at the San Antonio Breast Cancer Symposium 2015, according to a Roche media release.
- 11 Dec 2015 Early data published in a Roche media release.